DME

Rensponsive Diabetic Macular Edema

Slide10-9Slide10-9 Slide9-8Slide9-8 Slide8-7Slide8-7 Slide7-6Slide7-6 Slide6-5Slide6-5 Slide5-4Slide5-4 Slide4-3Slide4-3 Slide3-2Slide3-2 Slide2-1Slide2-1 Slide1-0Slide1-0

Image “Slide1.PNG”: introduction: medical history of the patient.

Image “Slide2.PNG”: baseline of both eyes before treatment.

Image “Slide3.PNG”: right eye: after the first IVI of Aflibercept 8mg.

Image “Slide4.PNG”: right eye: Aflibercept 8mg regimen q4.

Image “Slide5.PNG”: right eye: progression Aflibercept 8mg regimen q12.

Image “Slide6.PNG”: right eye: follow-up 8 months of treatment.

Image “Slide7.PNG”: left eye: after the first IVI of Aflibercept 8mg.

Image “Slide8.PNG”: left eye: Aflibercept 8mg regimen q4.

Image “Slide9.PNG”: left eye: progression Aflibercept 8mg regimen q12.

Image “Slide10.PNG”: left eye: follow-up 8 months of treatment.